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Damageto the kidneys isoneoftheprimarytoxic actions ofmetals. Nephrotoxic substances not
onlycauserenaldiseasedirectly, buttheycanalsodestroyrenalreservecapacity, potentiallyplac-
ing those people with additional risk factors, such as diabetes, hypertension, cardiovascular dis-
ease, and genetic predispositions, at greater risk. To detect nephrotoxicity in people at a stage
where intervention can be effective, sensitive methods are needed. One ofthe major advantages
ofusing sensitive biomarkers ofrenal damage is thatpeople who maybe particularly susceptible
to renal damage can be identified early, at a reversible stage ofdamage, and the progression to
end-stage renal disease maybehaltedordelayed. Various categoriesoftets can be usedtodetect
effects ofnephrotoxic subsances on the kidney. Through the use ofbiomarkers ofdamage to
various parts ofthe nephron, U.S. and European studies have both shown a similar pattern of
damage among men occupationally exposed to-cadmium. These studies indicate various thresh-
olds ofrenal effects, which researcherssuggest represent acascade ofprogressivelysevere damage
to the kidney. Research into newbiomarkers ofdamage caused byexposure to nephrotoxic sub-
stances centers around mechanisms ofcell death, induding necrosis and apoptosis; mechanisms
ofcell growth, regeneration, andproliferation, induding factors that control cellcle, influence
gene expression, and modulate nudeic acid synthesis; and genetic factors that increase suscepti-
bilityto renal disease. Examples oftypes ofcandidate biomarkers indudecytokines, lipid media-
tors, growth factors, transcription factors and protooncogenes, extracellular matrix components
(collagen, glycoproteins, andproteoglycans), andcell adhesion molecules. Research into newcat-
egories ofbiomarkers mayprovide additional insights into the mechanisms ofdamage causedby
nephrotoxins. Keywork biomarkers, cadmium, human, kidneys, lead, mercury, metals, nephro-
toxicity, solvents. Environ HealthPerspect106:227-230 (1998). [Online 23 March 1998]
htp://ehpnetl.niehs.nib.gov/docsl998/106p227-230Omuer/abstract.html
Damage to the kidneys is one ofthe prima-
ry toxic actions ofmetals, and nephrotoxici-
ty by heavy metals has been the focus of
much research. In the United States, renal
disease exacts a heavy burden, both in
human and economic terms. In 1990, for
example, approximately 165,000 people
received chronic dialysis therapy for end-
stage renal disease (ESRD), and another
9,800 people received renal transplants at a
cost to the federal government, alone, of
$5.22 billion (1). Nephrotoxic substances
not only cause renal disease directly, but
they can also destroy renal reserve capacity,
potentially placing people with additional
risk factors, such as diabetes, hypertension,
cardiovascular disease, and genetic predis-
positions, at greater risk.
To detect nephrotoxicity in people at a
stage where intervention can be effective, sen-
sitive methods are needed. The two kidneys
each contain 1.0-1.3 million independent
nephrons. Possibly one-third ofthe nephrons
could be lost to a chronic disease process or
nephrotoxicity without a noticeable reduc-
tion in the whole-kidney glomerular filtration
rate. If the remaining two-thirds of the
nephrons hypertrophied so that the single
nephron filtration rate increased by 50%,
the whole-kidney glomerular filtration rate
would remain the same. As a result, the kid-
ney can suffer considerable damage before
losing sufficient function to modify the nor-
mal clinical indicators of renal disease, such
as the serum creatinine concentration.
Approximately 50% or more ofrenal capaci-
ty can be lost before serum creatinine levels
become abnormal (2) and the disease is
detectable clinically. This lack of sensitivity
of the normal clinical indicators has led to
the use ofmore sensitive tests to detect dam-
age to various parts of the nephron. These
tests include indicators ofglomerular selec-
tivity, indicators of tubular protein reab-
sorption capability, and indicators of
turnover of tubular tissue. Active research
into new methods of further defining early
renal damage is ongoing. These new meth-
ods frequently provide a means ofquantify-
ing and describing the lowest measurable
human effects of nephrotoxic substances
such as metals, and therefore allow the
determination of the lowest limit of these
effects in humans. New methods also poten-
tially allow individuals who are particularly
susceptible to the effects ofnephrotoxic sub-
stances to be identified. A battery made up
of a combination of different types of tests
can aid in the quantitative description ofthe
pattern ofdamage ofa nephrotoxin and also
allow for the determination of various
thresholds ofdamage. The detection ofrenal
damage at a reversible stage is necessary
before effective preventive measures can be
taken to halt the progress of damage to the
irreversible stage.
Categories ofTests
Various categories of tests can be used to
detect effects ofnephrotoxic substances on the
kidney. Seven categories of tests were identi-
fied at the first U.S./European Union
Workshop, "Urinary Biomarkers to Detect
Significant Effects of Environmental an
Occupational Exposure to Nephrotoxins" (3):
I.Clinical indicators of renal disease: a
decrease in the glomerular filtration rate
(GFR) as determined by inulin, iothala-
mate, or creatinine clearance; an increase
in serum creatinine concentration; the
presence ofdip-stick positive proteinuria;
elevated serum cystatin C levels.
2.Early indicators of glomerular damage:
elevated albumin or transferrin excretion
without an increase in low molecular
weight (LMW) protein excretion; the
Address correspondence to P.W. Muteller, Centers for
Disease Control and Prevention, MS F50, 4770
Buford Highway NE, Atlanta, GA 30341-3724 USA.
Funding for the Joint United States/European
Union Workshop, "Urinary Biomarkers to Detect
Significant Effects of Environimental and
Occupational Exposure to Nephrotoxinis," was pro-
vided by the National Center for Environmental
Health, Centers for Disease Conitrol anid Prevention,
the European Commission and its Environmental
Research Program, the Agency for Toxic Substances
and Disease Registry (from the Comprehensive
Environmental Response, Compensation, and
Liability Act Trust Fund), the Nationial Inistitute of
Diabetes and Digestive and Kidney Diseases, the
National Institute for Environimental Health
Sciences, and Bayer Corporation.
Received 8 September 1997; accepted 1 1 December
1997.





.c. eviex,./vs,-Reviews * Mueller et al.
excretion ofextracellular matrix proteins
ofglomerular derivation.
3.Early indicators of damage to the tubular
protein absorption capability: elevated
excretion of retinol-binding protein
(RBP), P2-microglobulin (P2m, unstable
in some urine samples), or Clara cell pro-
tein (a more sensitive indicator inwomen).
4.Indicators ofdirect release oftubular tis-
sue into urine: increased urinary excre-
tion of N-acetyl-fB-D-glucosaminidase
(NAG, lysosomal), intestinal alkaline
phosphatase (IAP), alanine aminopepti-
dase (AAP), and tubular antigens.
5.Early indicators of damage to the distal
tubule: loss of urine-concentrating abili-
ty, as indicated by decreased urine osmo-
lality; increased excretion of Tamm-
Horsfall protein and n glutathione S-
transferase; changes in epidermal growth
factor (EGF) excretion.
6.Early indicators of interstitial damage:
none available.
7.Changes in prostaglandin synthesis.
Some of these tests have been used in
human studies (e.g., GFR, serum creati-
nine, osmolality, urine albumin, RBP,
NAG, AAP, IAP, and P2m), and their
behavior has been characterized in response
to exposures to different nephrotoxic met-
als (49) as well as other nephrotoxic sub-
stances. Other tests have not been used in
as many human studies of nephrotoxicity
and are not as well characterized.
Thresholds ofEffects: Cadmium
The renal toxicity of cadmium has been
studied more extensively than that ofother
heavy metals. Through the use ofbiomark-
ers of damage to various parts of the
nephron, a pattern of damage is emerging
that is consistently observed now both in
U.S. and European studies ofmen occupa-
tionally exposed to cadmium (4-10).
These studies indicate various thresholds of
renal effects, which European investigators
have suggested represent a cascade of pro-
gressively severe damage to the kidney
(3,11). The observed thresholds are based
on a significant increase in the prevalence
of abnormal values. Test values become
abnormal in the most susceptible individu-
als first, and with increasing cadmium
exposure the number of individuals with
abnormal values increases. These thresh-
olds are discussed below.
The lowest observed effect is indicated
by a significant prevalence of abnormal 6-
keto-prostaglandin Fla (6-keto-PGFi,a) and sialic acid levels in urine at an approxi-
mate urine cadmium concentration of 2.4
nmol Cd/mmol creatinine (2.4 pg Cd/g
creatinine) (10). Proteins such as albumin
and transferrin originate in the plasma and
are filtered to a limited degree through the
glomerulus, and the protein that is filtered
is primarily reabsorbed by the tubules.
When tubular protein reabsorption is nor-
mal, as indicated by normal excretion of
LMW proteins such as RBP and 32m, ele-
vations in the excretion of albumin and
transferrin indicate changes in glomerular
selectivity. Significant elevations in the
excretion of albumin and transferrin occur
at urine cadmium concentrations from 3.6
to 4.2 nmol Cd/mmol creatinine (3.6-4.2
pg Cd/g creatinine) (5,10).
Significantly increased excretion of
indicators ofdirect release oftubular tissue,
such as brush-border antigens, NAG, IAP,
and AAP, occurs at urine cadmium con-
centrations between 3.7 and 6.3 nmol
Cd/mmol creatinine (3.7 and 6.3 pg Cd/g
creatinine) (5,10). Increased excretion of
the LMW proteins RBP or B2m is a sensi-
tive indicator ofdamage to the tubules and
loss of tubular protein reabsorption capa-
bility (3). These LMW proteins are nor-
mally freely filtered through the glomerulus
and primarily reabsorbed by the tubules.
Significant elevations in the excretion of
these proteins occur at urine cadmium lev-
els between 6.5 and 11.5 nmol Cd/mmol
creatinine (6.5 and 11.5 pg Cd/g creati-
nine) (5,10). Increased excretion ofTamm-
Horsfall glycoprotein (at 7.0 nmol
Cd/mmol creatinine or pg Cd/g creati-
nine), which has been suggested as an indi-
cator of distal tubular damage, and
increased excretion of glycosaminoglycans
(at 11.5 nmol Cd/mmol creatinine or pg
Cd/g creatinine) also occur in this same
urine cadmium range (10).
These thresholds are based on studies of
occupational exposures. At least three stud-
ies ofenvironmental exposures have shown
that cadmium causes elevated biomarker
test results at lower cadmium levels than
among occupationally exposed workers
(10,12,13). Although the health signifi-
cance ofthese findings has not been deter-
mined, one explaination for the difference
is that the general population may contain
more susceptible people than a healthy
working population (10).
The relatively few studies of women
exposed to cadmium in which the data
were analyzed separately by gender indicate
a different pattern ofdamage among young
women than among occupationally
exposed men, with the damage becoming
apparent in women primarily after the age
of menopause (5,14-17). Another differ-
ence between men and women was report-
ed in a Swedish study of workers exposed
to cadmium in a battery factory. In this
study, researchers found that the percent-
age of workers with kidney stones was
lower among women (2.1%) than among
men (12.0%) (18). In a recent study in
Japan of people 56-71 years old (past the
mean age of menopause for women) who
had been environmentally exposed to cad-
mium, no difference between men and
women in the incidence or severity ofrenal
tubular dysfunction was found (19). In
another Japanese study, a 15-year follow-
up study of people initially >50 years old
showed that men and women had similar
prevalences ofhigh RBP excretion (20).
Health Significance ofAbnormal
TestValues
The clinical significance ofthree categories
oftests has been studied to varying degrees.
Increased albumin excretion has been epi-
demiologically associated with, and is pre-
dictive of, renal disease among people with
insulin-dependent diabetes mellitus (21).
Among people with non-insulin-depen-
dent diabetes mellitus, those with hyper-
tension (without diabetes), and those in the
general population (the Framingham
Study), increased albumin excretion and
proteinuria are primarily associated with
excess cardiovascular disease, mortality, and
renal disease (21). Persistent high-grade
proteinuria is associated with a progressive
loss of renal function, and once present
may, by itself, contribute to the secondary
development of tubulointerstitial injury.
Elevated albumin excretion has also been
shown to be a sensitive, although not spe-
cific, indicator of analgesic nephropathy
(22). Appropriate long-term studies of the
clinical significance of the elevations in
albumin excretion associated with metal
exposures have not been done.
The second category of tests for which
long-term studies are available is that of
LMW proteins. Roels and co-workers have
conducted long-term studies of the impli-
cations of elevated LMW proteinuria
among cadmium workers and found that
the LMW proteinuria that occurs when the
cadmium level in urine exceeds 10 nmol
Cd/mmol creatinine (10 pg Cd/g creati-
nine) is irreversible (10,23) and that it is
associated with both an exacerbation ofthe
age-related decline in the glomerular filtra-
tion rate based on estimates from serum
,2m levels (10,24) and a reduction ofpro-
tein-induced short-term hyperfiltration (fil-
tration reserve capacity) (10,25). Bernard
[see Bernard et al. (11)] suggested four
thresholds of LMW proteinuria (RBP or
02m): 1) <300 pg/g creatinine should be
regarded as normal, 2) 300-1,000 jig/g cre-
atinine indicates incipient cadmium tubu-
lopathy (possibly reversible after removal
from exposure) with no change in the
GFR, 3) 1,000-10,000 jg/g creatinine
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indicates irreversible tubular proteinuria,
which may lead to an accelerated decline of
the GFR with age (GFR is normal or
slightly impaired), and 4) >10,000 pg/g
creatinine indicates overt cadmium
nephropathy, usually associated with
decreased GFR. In a recent Swedish study,
researchers reported associations between
abnormal f32m excretion and a steeper dose
response between cadmium exposure and
renal calculi (kidney stones) (18). In one
Japanese study ofenvironmental cadmium
exposure, investigators found relationships
between an elevated fractional excretion of
02m and the results of a number ofclinical
tests, including increases in the fractional
excretion of urate, calcium, sodium, and
chloride and decreases in fractional phos-
phate reabsorption and creatinine clearance
(19). In a 15-yearJapanese follow-up study
of a different environmental exposure to
cadmium, investigators found an associa-
tion between RBP excretion .4 mg/I and
an increased risk of death from cardiovas-
cular disease and from renal disease among
both men and women and an increased
risk of diabetes mellitus among women
(20).
The third category oftests forwhich data
on clinical significance exist is that of
enzymes or renal antigens, the origin of
which is primarily the renal tubule itself
rather than plasma. Membrane-bound pro-
teins are released into the urine as a result of
necrosis, apoptosis, and regenerative process-
es, and these regenerative processes can take
different forms depending on whether the
damage is acute or chronic (26). Changes in
enzyme excretion can relate to regulation of
exocytotic and endocytotic transport. Levels
ofvarious enzymes have been shown to be
elevated in animals in conjunction with
changes in renal function and exfoliation of
renal tubular cells induced by administration
of mercuric chloride (27,28). In humans, a
model ofthe response ofthese types ofpro-
teins to nephrotoxicity is the response to cis-
platin chemotherapy. Cisplatin causes cystic
alterations, tubular loss, inflammation, and
multiple areas ofhyperplasia in the kidneys
of rats (29). Goren et al. (30) have shown
that NAG and AAP activities increase in
humans 3 days after receiving cisplatin ther-
apy, just as tubular necrosis appears in rats 3
days after exposure to cisplatin. Goren and
co-workers also observed a chronic baseline
rise in NAG activity in children following
the activity spikes that occur with each cis-
platin dose. Increased levels of NAG and
AAP activity have also been associated with
loss of renal tubular secretion function.
They found that NAG and AAP activities
were associated with significant increases in
the half-life of methotrexate, a drug that is
substantially secreted by the tubules of
patients who have received cisplatin, and
that NAG activity, in particular, was predic-
tive of impaired renal excretion of
methotrexate (31).
There are few, if any, data on the
health significance ofchanges in other cate-
gories oftests. A more definitive picture of
the relationship between various biomark-
ers of nephrotoxicity and the development
of renal disease awaits more extensive
prospective studies and studies using clini-
cal models ofnephrotoxicity.
Potential NewBiomarkers
Research into new biomarkers of damage
caused by exposure to nephrotoxic sub-
stances focuses on several major areas.
These areas include research into mecha-
nisms ofcell death, including necrosis and
apoptosis; research into mechanisms ofcell
growth, regeneration, and proliferation,
including factors that control cell cycle,
influence gene expression, and modulate
nucleic acid synthesis; and research into
factors that increase susceptibility to renal
disease, including preexisting conditions
and genetic factors (1,3,32).
Examples of types of candidate bio-
markers include cytokines, lipid mediators,
growth factors, transcription factors and
protooncogenes, extracellular matrix com-
ponents (collagen, glycoproteins, and pro-
teoglycans), and cell adhesion molecules
(32). Some of these candidate markers are
beginning to be examined in human stud-
ies. Excretion of fibronectin has been
examined in relation to exposure to three
heavy metals (cadmium, lead, and mer-
cury), with no significant changes in excre-
tion seen in the exposed groups (7-9).
Excretion ofprostanoids [6-keto-PGFiu,
PGE2, PGF2a, and thromboxane B2
(TXB2)] was examined in the same three
heavy metal exposure studies (7-9), with dif-
ferent results for exposures to mercury, lead,
and cadmium. PGI2 (measured as the stable
urinary derivative 6-keto-PGFi.) and PGE2
are vasodilators and contribute to mesangial
relaxation, whereas PGF2I and TXB2 are
vasoconstrictors and/or contribute to mesan-
gial contraction (3). In the case of mercury
exposure, the excretion of PGE2, PGF2a,
and TXB2 were all significantly loweramong
the exposed workers. Among workers
exposed to lead, the excretion ofthevasodila-
tor PGI2 was significantly lower than in con-
trols, whereas the excretion of the vasocon-
strictor TXB2 was significantly higher.
Cadmium exposure among workers was
associated with increased excretion of both
6-keto-PGFiu and PGE2 and no change in
the excretion of PGF2a or TXB2' These
findings may have mechanistic implications
for the controversial question ofhow metal
exposure, especially exposure to lead, affects
blood pressure (8).
In rats, renal excretion ofEGF has been
shown to decrease immediately in response
to the release of ischemia in the rat (33).
Human studies of EGF excretion have
been largely limited to people with diabetes
and have generally shown that under near-
normal glycemic conditions, EGF excre-
tion correlates with the GFR (34), and
EGF excretion may decrease with progres-
sive diabetic complications (35). Under
hyperglycemic conditions, however, there
were indications that EGF excretion may
increase (35). EGF has been suggested as
an indicator of distal tubular damage,
which may be more closely related to
changes in the GFR than some other class-
es ofmarkers (32).
Another distal tubular marker that has
been proposed recently is n glutathione S-
transferase (iGST). Whereas aGST is
found primarily in the proximal convolut-
ed tubules ofthe kidney, iGST is found in
the distal convoluted tubules, the thin loop
ofHenle, and the collecting ducts (36,37).
Damage to the epithelial cell membranes in
these regions results in increased excretion
ofthis isoenzyme (37). It has been suggest-
ed that excretion of different isoforms of
GST may distinguish between certain
pathological processes in the kidney (38).
The best approach for validation ofnew
biomarkers is an issue that received consid-
erable discussion in the U.S./EU workshop.
Long-term follow-up studies of cohorts
occupationally exposed to cadmium was
suggested and discussed (11). Although this
might be feasible with existing cohorts,
three considerations were raised with regard
to this type of study: ethical concerns
because ofthe need to remove workers from
exposure, which might also reverse effects;
the "healthy worker effect," which limits
extrapolation of the conclusions, and the
increasing difficulty of finding highly
exposed workers because of lower exposure
levels. The final recommendation of the
workshop was to examine the use ofclinical
models of nephrotoxicity to evaluate new
biomarkers and to study the development
ofrenal disease.
Conclusions
It is now possible to draw a more accurate
picture ofearly damage to the human kid-
ney by nephrotoxic substances such as met-
als. It is possible to define levels of body
burden or exposure in humans that are
associated with various levels of damage
indicated by different types of biomarkers.
Research into new categories ofbiomarkers
may provide additional insights into the
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mechanisms of damage caused by nephro-
toxins. Although a variety of biomarkers
are frequendy used when studying nephro-
toxic substances, as new information
becomes available on individual toxicants
and particular combinations of toxicants,
smaller, more focused batteries ofbiomark-
ers can be used to describe the characteris-
tic pattern ofdamage.
One of the major advantages of using
sensitive biomarkers ofrenal damage is that
people who may be particularly susceptible
to renal damage may be identified early,
when damage to their kidneys is reversible
and the progression to end-stage renal dis-
ease may be halted or delayed (39). In
addition, during the next 10 years, genetic
factors may be found that may be associat-
ed with susceptibility to various types of
toxicity, including renal toxicity.
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